ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT
Cook Medical Incorporated · Decision date Sep 18, 2025
What did the FDA approve?
FDA records P140016/S015 as a supplement to PMA P140016, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 18, 2025.
FDA approval order statement
Approval for a change in coating for the delivery system of the Zenith Alpha 2 Thoracic Endovascular Graft
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 18, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P140016/S015
- Regulatory pathway
- PMA supplement
- Applicant
- Cook Medical Incorporated
- Product code
- MIH
- Decision code
- APPR
- Decision date
- Sep 18, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Cook Medical Incorporated
- Product code
- MIH
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P140016/S015 received
Application receipt date recorded by FDA.
P140016/S015 · FDA decision
Real-Time Process
P140016/S016 · Related supplement
Zenith Alpha Thoracic Endovascular Graft
P140016/S017 · Related supplement
Zenith Alpha Thoracic Endovascular Graft; Zenith Dissection Endovascular System
P140016/S018 · Related supplement
Zenith Alpha/ Alpha 2 Thoracic Endovascular Graft (ZTA/ZTA2)
Timeline entries are records held by MedtechLedger for P140016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Zenith Alpha Thoracic Endovascular GraftP140016/S016 | Cook Medical Incorporated | PMA supplement | May 8, 2026 | FDA |
| Cook Medical Incorporated | PMA supplement | May 21, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA | |
GORE EXCLUDER Conformable AAA EndoprosthesisP200030/S026 | W. L. Gore and Associates, Inc. | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Medical Incorporated
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- Sandet 6, Bjaeverskov, 4632
Sources and methodology
- Original FDA record: P140016/S015
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





